Prolacta Bioscience Celebrates 125,000 Preemies Supported by Nutrition
Milestone in NICU Care: 125,000 Preemies Supported
In an inspiring celebration of NICU Awareness Month, Prolacta Bioscience is thrilled to announce that over 125,000 premature infants have benefited from its pioneering nutritional products. These products, crafted entirely from donor breast milk, emphasize the importance of human milk in caring for critically ill and preterm infants.
The Role of Breast Milk in Neonatal Health
Prolacta's fortifiers and formulas are not only safe but have been proven to reduce severe complications associated with prematurity, such as necrotizing enterocolitis (NEC), a potentially life-threatening intestinal disorder. By exclusively using human milk, Prolacta has been redefining the standard care for the tiniest and most vulnerable infants since its introduction of the world's first human milk-based fortifier in 2006.
Advancements in NICU Care
Every September, NICU Awareness Month is observed to highlight the invaluable care provided to premature and medically vulnerable newborns. In the U.S. alone, approximately 36,000 babies are born weighing less than 2.75 pounds each year. Many of these infants face significant health risks, but thanks to enhanced nutrition backed by rigorous research, they are not just surviving—they are thriving.
Impact on Families
For many families, the announcement of helping over 125,000 preemies goes beyond mere statistics; it represents real lives positively impacted by breast milk-based nutrition. Scott Elster, CEO of Prolacta, emphasized the commitment of NICU care teams nationwide, noting how breast milk-based nutrition can dramatically affect the health and outcomes for these fragile infants during critical periods.
Importance of Exclusive Human Milk Diet
Research has solidly established that an Exclusive Human Milk Diet (EHMD) significantly improves survival rates and minimizes the complications of prematurity among the most fragile infants. This diet utilizes Prolacta's breast milk-based nutritional fortifiers, revealing substantial benefits compared to traditional cow milk-based products.
Long-Term Developmental Outcomes
Breast milk-based nutrition is associated with substantial long-term developmental advantages. Recent independent studies have shed light on the benefits of an EHMD, linking it to better motor function performance at ages as young as three years. Such studies underscore the vital role of nutrition in supporting healthy growth trajectories.
A Commitment to Quality and Safety
Prolacta Bioscience is rooted in Advancing the Science of Human Milk, dedicated to enhancing health outcomes for critically ill and premature infants. With products evaluated in over 30 clinical studies, Prolacta is leading advancements in neonatal nutrition, including the recent introduction of Surgifort, the only FDA-approved human milk-based fortifier designed for term infants recovering from gastroschisis corrective surgery.
Ensuring Safety and Bioactivity
Boasting some of the industry's most rigorous quality and safety standards, Prolacta employs highly sophisticated manufacturing processes. Their facilities utilize vat pasteurization designed not only to inactivate pathogens but also to maintain the nutritional integrity and functional bioactivity of the human milk used.
Learn More About Prolacta Bioscience
For further insights into how Prolacta's products are reshaping neonatal nutrition, information can be accessed through various communication channels and social media platforms. The focus remains steadfast on supporting the tiniest patients and their families during critical times.
Frequently Asked Questions
What is Prolacta Bioscience known for?
Prolacta Bioscience specializes in 100% human milk-based nutritional products for premature and critically ill infants.
Why is breast milk important for premature infants?
Breast milk significantly reduces the risk of life-threatening complications, enhances survival rates, and supports healthy development in premature babies.
How many preemies has Prolacta helped?
Prolacta has positively impacted over 125,000 premature infants worldwide with its innovative nutritional formulas.
What unique product does Prolacta offer?
Prolacta's unique offering includes the world's first and only 100% human milk-based fortifier, introduced in 2006.
How does Prolacta ensure product safety?
Prolacta maintains strict quality control through advanced manufacturing processes, including vat pasteurization to preserve milk bioactivity.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.